Page last updated: 2024-08-26

u 74006f and Brain Vascular Disorders

u 74006f has been researched along with Brain Vascular Disorders in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clark, WM; Coull, BM; Hazel, JS1
Bednar, MM; Booth, C; Gross, CE; Kimelberg, HK; Raymond-Russell, S1
Haley, EC1
Beck, T; Bielenberg, GW1
Braughler, JM; Hall, ED; McCall, JM1

Reviews

2 review(s) available for u 74006f and Brain Vascular Disorders

ArticleYear
Lazaroids. CNS pharmacology and current research.
    Drugs, 1995, Volume: 50, Issue:6

    Topics: Antioxidants; Brain Injuries; Cerebrovascular Disorders; Free Radical Scavengers; Humans; Lipid Peroxides; Pregnatrienes; Spinal Cord Injuries

1995
Role of oxygen radicals in stroke: effects of the 21-aminosteroids (lazaroids). A novel class of antioxidants.
    Progress in clinical and biological research, 1990, Volume: 361

    Topics: Animals; Cerebrovascular Disorders; Free Radicals; Lipid Peroxides; Oxygen; Pregnatrienes

1990

Trials

3 trial(s) available for u 74006f and Brain Vascular Disorders

ArticleYear
Safety study of tirilazad mesylate in patients with acute ischemic stroke (STIPAS).
    Stroke, 1994, Volume: 25, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Free Radical Scavengers; Humans; Infusions, Intravenous; Lipid Peroxides; Male; Middle Aged; Pregnatrienes; Time Factors; Treatment Outcome

1994
A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). The RANTTAS Investigators.
    Stroke, 1996, Volume: 27, Issue:9

    Topics: Activities of Daily Living; Aged; Antioxidants; Cerebrovascular Disorders; Double-Blind Method; Female; Glasgow Coma Scale; Humans; Injections, Intravenous; Lipid Peroxides; Male; Middle Aged; Pregnatrienes; Prospective Studies; Survival Analysis; Time Factors; Treatment Outcome

1996
High-dose tirilazad for acute stroke (RANTTAS II). RANTTAS II Investigators.
    Stroke, 1998, Volume: 29, Issue:6

    Topics: Acute Disease; Cerebrovascular Disorders; Female; Humans; Male; Neuroprotective Agents; Pregnatrienes

1998

Other Studies

2 other study(ies) available for u 74006f and Brain Vascular Disorders

ArticleYear
Delayed adjuvant therapy with the 21-aminosteroid U74006F and the anion channel blocker L644-711 does not improve outcome following thrombolytic therapy in a rabbit model of thromboembolic stroke.
    Surgical neurology, 1997, Volume: 47, Issue:1

    Topics: Animals; Anions; Biological Transport; Cerebrovascular Circulation; Cerebrovascular Disorders; Chemotherapy, Adjuvant; Disease Models, Animal; Female; Fluorenes; Male; Neuroprotective Agents; Pregnatrienes; Rabbits; Thromboembolism; Thrombolytic Therapy; Time Factors; Treatment Outcome

1997
The effects of two 21-aminosteroids on overt infarct size 48 hours after middle cerebral artery occlusion in the rat.
    Brain research, 1991, Sep-27, Volume: 560, Issue:1-2

    Topics: Animals; Arterial Occlusive Diseases; Cerebral Infarction; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Pregnatrienes; Rats; Rats, Inbred F344; Steroids

1991